Plain English Summary

Many new medicines are used to treat multiple illnesses. However, the benefits a medicine provides can differ depending on the condition it is used to treat. In the UK, the NHS pays a price for a new medicine that reflects the level of benefit it delivers to patients. This raises an important question: should the NHS pay different prices for the same drug when it is used to treat different conditions, or should there be a single price for a medicine?

This project aims to explore and evaluate the potential impact of different pricing strategies for medicines used across multiple conditions. We will conduct analyses to predict how various pricing methods might affect patient access to medicines, NHS spending, and long-term outcomes such as the impact on future research and development decisions. We will also look into how different pricing strategies could affect the way the NHS evaluates and pays for new medicines.